{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Panuveitis&page=4", "query": { "condition": "Panuveitis", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 92, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Panuveitis&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Panuveitis&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T08:55:47.261Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07513623", "title": "Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cytomegalovirus (CMV)", "Anterior Uveitis", "Infectious Uveitis", "CMV Infection" ], "interventions": [ { "name": "Valganciclovir", "type": "DRUG" }, { "name": "Ganciclovir (GCV)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 117, "start_date": "2026-11-01", "completion_date": "2032-10-31", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 2, "location_summary": "Los Angeles, California • San Francisco, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07513623" }, { "nct_id": "NCT01693653", "title": "Tocilizumab for the Treatment of Behcet's Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Behcet Syndrome" ], "interventions": [ { "name": "Tocilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2012-09", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01693653" }, { "nct_id": "NCT05070728", "title": "Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uveitis", "Uveitis, Posterior", "Uveitis, Intermediate" ], "interventions": [ { "name": "Sham Injector", "type": "DRUG" }, { "name": "FAI Insert", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EyePoint Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2021-10-13", "completion_date": "2023-04-12", "has_results": true, "last_update_posted_date": "2024-12-19", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05070728" }, { "nct_id": "NCT02190929", "title": "Educational Needs of Patients With Systemic Vasculitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Behcet's Disease", "Churg-Strauss Syndrome", "Vasculitis, Central Nervous System", "Giant Cell Arteritis", "Wegener Granulomatosis", "Henoch-Schoenlein Purpura", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu's Arteritis" ], "interventions": [], "intervention_types": [], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 386, "start_date": "2012-03", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02190929" }, { "nct_id": "NCT05635266", "title": "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet's Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo" ], "interventions": [ { "name": "Specimen sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20000, "start_date": "2021-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635266" }, { "nct_id": "NCT07699107", "title": "Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Juvenile Idiopathic Arthritis Associated Uveitis", "Uveitis, Anterior" ], "interventions": [ { "name": "Adalimumab/Biosimilar", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Nisha Acharya", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 160, "start_date": "2026-09", "completion_date": "2030-11", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 9, "location_summary": "Los Angeles, California • Sacramento, California • San Francisco, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07699107" }, { "nct_id": "NCT01717170", "title": "Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Intermediate Uveitis", "Posterior Uveitis", "Pan-uveitis" ], "interventions": [ { "name": "Tocilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 36, "start_date": "2013-03", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2017-04-28", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01717170" }, { "nct_id": "NCT03410290", "title": "Journey of Patients With Vasculitis From First Symptom to Diagnosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Vasculitis", "Systemic Vasculitis", "Behcet's Disease", "CNS Vasculitis", "Cryoglobulinemic Vasculitis", "Eosinophilic Granulomatous Vasculitis", "Temporal Arteritis", "Giant Cell Arteritis", "Granulomatosis With Polyangiitis", "Wegener Granulomatosis", "Henoch Schonlein Purpura", "IgA Vasculitis", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu Arteritis", "Urticarial Vasculitis" ], "interventions": [ { "name": "Online Questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 456, "start_date": "2018-01-11", "completion_date": "2018-05-21", "has_results": false, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03410290" }, { "nct_id": "NCT02176070", "title": "Reproductive Health in Men and Women With Vasculitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Giant Cell Arteritis", "Takayasu's Arteritis", "Polyarteritis Nodosa", "Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg-Strauss Syndrome", "Behcet's Disease", "Kawasaki Disease", "Henoch-schoenlein Purpura", "Vasculitis, Central Nervous System", "Drug-induced Necrotizing Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 467, "start_date": "2011-02", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2014-06-26", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02176070" }, { "nct_id": "NCT06431373", "title": "A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uveitis, Posterior", "Uveitis, Intermediate", "Uveitis" ], "interventions": [ { "name": "Brepocitinib PO QD", "type": "DRUG" }, { "name": "Placebo PO QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Priovant Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 371, "start_date": "2024-09-11", "completion_date": "2028-02-01", "has_results": false, "last_update_posted_date": "2026-01-12", "last_synced_at": "2026-10-22T08:55:47.261Z", "location_count": 53, "location_summary": "Phoenix, Arizona • Bakersfield, California • Beverly Hills, California + 44 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06431373" } ] }